Acute retinal necrosis refractory to treatment.

BMJ Case RepOct 7, 2026 (epub)
Case ReportOphthalmology

Ian R Reekie, Jekaterina Sidhom, Randhir Chavan

✦ AI-curated · Sources linked

Case in brief

A woman in her 60s presented with hypertensive uveitis in the right eye, followed by vitritis and retinitis. An anterior chamber sample was positive for herpes simplex virus by PCR. Retinal necrosis and haemorrhages progressed despite oral valaciclovir and an initial intravitreal foscarnet injection. Repeat sampling identified aciclovir-resistant viral strains. Repeated intravitreal and intravenous foscarnet temporarily stabilised the condition, but the retina later detached.

What made this case unusual

Progression despite antiviral treatment prompted repeat PCR testing, which confirmed aciclovir-resistant herpes simplex virus in a case of acute retinal necrosis.

Diagnostic / clinical pearl

When acute retinal necrosis worsens or fails to stabilise on initial antiviral therapy, consider antiviral resistance and reassess with virological testing.

Why it matters

Intravenous foscarnet may carry unpleasant and potentially dangerous adverse effects, so patients should be counselled about these risks.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.